Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

1. Hernández-Cruz, B.
2. Otero-Varela, L.
3. Freire-González, M.
4. Busquets-Pérez, N.
5. González, A.J.G.
6. Moreno-Ramos, M.
7. Blanco-Madrigal, J.M.
8. Manrique-Arija, S.
9. Perez-Pampin, E.
10. Ruiz-Montesino, D.
11. Sánchez-Alonso, F.
12. Sanchez-Piedra, C.
13. Castrejón, I.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1136/ARD-2023-225271 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus